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Adaptation of a DNA Replication Checkpoint
Response Depends upon Inactivation of
Claspin by the Polo-like Kinase
(Kumagai and Dunphy, 2000). These templates appear
to mimic incompletely replicated DNA in the extracts.
In vertebrates, the activation of Chk1 depends upon
ATR, which is homologous to budding yeast Mec1 and
fission yeast Rad3 (Guo et al., 2000; Hekmat-Nejad et
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al., 2000; Liu et al., 2000). In egg extracts, XenopusPasadena, California 91125
ATR (Xatr) carries out the activating phosphorylation2 Max Planck Institute of
of Xchk1 on four conserved Ser-Gln/Thr-Gln (SQ/TQ)Molecular Cell Biology and Genetics
motifs in its C-terminal regulatory domain (Guo et al.,Pfotenhauerstrasse 108
2000). The Xatr-dependent phosphorylation of Xchk101307 Dresden
also depends on another protein called Claspin (Kuma-Germany
gai and Dunphy, 2000, 2003; Jeong et al., 2003; Lee et al.,
2003). In this system, there is also a parallel replication
checkpoint pathway that operates independently ofSummary
Xatr, Claspin, and Xchk1 (Kumagai et al., 1998; Guo et
al., 2000; Kumagai and Dunphy, 2000). A similar phe-The checkpoint mediator protein Claspin is essential
nomenon has recently been described in mammalianfor the ATR-dependent activation of Chk1 in Xenopus
cells (Brown and Baltimore, 2003).egg extracts containing aphidicolin-induced DNA repli-
Since Claspin also binds to Xchk1, a simple model iscation blocks. We show that, during this checkpoint re-
that Claspin promotes the phosphorylation of Xchk1 bysponse, Claspin becomes phosphorylated on threo-
Xatr by serving as a mediator or adaptor protein. Innine 906 (T906), which creates a docking site for Plx1,
addition to this function, Claspin associates with chro-the Xenopus Polo-like kinase. This interaction promotes
matin in a highly regulated manner during S phase (Leethe phosphorylation of Claspin on a nearby serine (S934)
et al., 2003). The binding of Claspin to chromatin de-by Plx1. After a prolonged interphase arrest, aphidicolin-
pends upon the prereplication complex (pre-RC),treated egg extracts typically undergo adaptation and
Cdc45, and Cdk2. These observations suggest thatenter into mitosis despite the presence of incompletely
Claspin may also act as a sensor of DNA replicationreplicated DNA. In this process, Claspin dissociates
forks. Functional homologs of Claspin called Mrc1 werefrom chromatin, and Chk1 undergoes inactivation. By
identified subsequently in budding and fission yeast (Al-contrast, aphidicolin-treated extracts containing mu-
casabas et al., 2001; Tanaka and Russell, 2001). Liketants of Claspin with alanine substitutions at positions
Claspin, Mrc1 also associates with the replication appa-906 or 934 (T906A or S934A) are unable to undergo
ratus in yeast cells (Katou et al., 2003; Osborn andadaptation. Under such adaptation-defective condi-
Elledge, 2003).tions, Claspin accumulates on chromatin at high lev-
Once Chk1 becomes activated, it prevents the entryels, and Chk1 does not decrease in activity. These
into mitosis by blocking activation of the Cdc2-cyclin Bresults indicate that the Plx1-dependent inactivation
complex. This process involves inhibition of Cdc25 andof Claspin results in termination of a DNA replication
stimulation of Wee1, both of which are critical upstreamcheckpoint response.
regulators of Cdc2-cyclin B (Melo and Toczyski, 2002).
The Xenopus Polo-like kinase (Plx1), which phosphory-Introduction
lates and activates Cdc25, is also involved in the entry
into mitosis (Kumagai and Dunphy, 1996; Nigg, 2001).
In eukaryotic cells, various checkpoint control mecha-
Plk1 is downregulated in human cells containing double-
nisms have evolved to maintain the integrity of the ge- stranded DNA breaks (Smits et al., 2000). It has not
nome. For example, these regulatory pathways prevent previously been reported whether Plx1 is negatively reg-
the entry into mitosis if the cell contains incompletely ulated in Xenopus egg extracts containing DNA replica-
replicated or damaged DNA (reviewed in Melo and Toc- tion blocks.
zyski, 2002; Osborn et al., 2002). The checkpoint re- One important aspect of checkpoint control involves
sponse to incompletely replicated DNA can be studied the issue of how checkpoint-mediated arrests of the
in cell-free extracts from Xenopus eggs (Dasso and cell cycle come to an end. In the case of DNA damage
Newport, 1990; Kumagai et al., 1998). In this system, responses, for example, the completion of DNA repair
treatment with the DNA replication inhibitor aphidicolin results in elimination of the checkpoint-activating signal,
causes the formation of DNA replication blocks. These reversal of the checkpoint-signaling reactions, and re-
stalled replication forks elicit activation of Xchk1, the covery processes. A more intriguing manner for termi-
Xenopus homolog of the checkpoint effector kinase nation of a checkpoint arrest entails a process called
Chk1 (Kumagai et al., 1998). The activation of Xchk1 in adaptation. During adaptation, the checkpoint arrest be-
egg extracts can also be triggered by addition of model comes alleviated before the checkpoint-inducing DNA
DNA templates such as annealed oligomers of poly(dA)70 signal has been removed. This process has been most
and poly(dT)70 (which we will refer to as pA-pT below) well characterized in the response of budding yeast to
double-stranded DNA breaks (Sandell and Zakian, 1993;
Toczyski et al., 1997; Pellicioli et al., 2001; Vaze et al.,*Correspondence: dunphy@cco.caltech.edu
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2002; Leroy et al., 2003). In unicellular organisms such (Plx1-N172A-GH). As shown in Figure 1D, Claspin asso-
ciated specifically with nickel beads containing Plx1-as yeast, adaptation may allow proliferation in cases
where DNA damage that cannot be repaired in a timely N172A-GH. There was no binding to control nickel beads
(data not shown). The binding of Claspin to Plx1-N172A-manner is nonetheless survivable. The prevalence and
biological role of checkpoint adaptation in multicellular GH was also greatly enhanced in the presence of pA-
pT. Addition of caffeine, an inhibitor of ATR and ATM,organisms are unknown. In budding yeast, adaptation
requires Cdc5 (the Polo-like kinase), Ckb1 and Ckb2 abolished the increased association of Plx1 and Claspin.
Thus, according to three different methods, Plx1 and(subunits of casein kinase II), Ptc2 and Ptc3 (PP2C-like
phosphatases), and the Srs2 helicase (Toczyski et al., Claspin form a specific, checkpoint-regulated complex.
1997; Pellicioli et al., 2001; Vaze et al., 2002; Leroy et
al., 2003). In fission yeast, phosphorylation of the Chk1- Phosphorylation of Claspin on T906 Recruits Plx1
regulatory protein Crb2 by Cdc2 is necessary for exit To characterize the interaction between Claspin and
from a DNA damage arrest (Esashi and Yanagida, 1999; Plx1, we attempted to identify the Plx1 binding site on
Caspari et al., 2002). Despite these significant insights, Claspin. For the binding assay, we incubated various 35S-
no primary regulatory circuit for adaptation of a cell cycle labeled fragments of Claspin in egg extracts containing
checkpoint arrest has been delineated in any organism. recombinant Plx1-N172A-GH in the absence and pres-
In this report, we show that the Xenopus Polo-like ence of pA-pT. Subsequently, we reisolated tagged Plx1
kinase Plx1 promotes inactivation of Claspin in aphidi- and examined binding of the 35S-labeled Claspin frag-
colin-treated Xenopus egg extracts after a prolonged ments by gel electrophoresis and phosphorimaging. Ini-
interphase arrest. As a consequence, the extracts enter tial experiments indicated that Plx1 binds to fragments
mitosis despite the ongoing presence of DNA replication from the C-terminal end of Claspin (e.g., residues 776–
blocks. These studies indicate that inactivation of a 1285 and 776–1174) but not to an N-terminal fragment
checkpoint mediator protein such as Claspin by a mi- (residues 1–744) (Figure 1E). Further detailed mapping
totic regulatory kinase results in checkpoint adaptation. indicated that residues 878–920 of Claspin are essential
In principle, such adaptive processes in multicellular for binding to Plx1 (see Figure 1F).
organisms could promote cell death or lead to the per- The Polo-like kinase (Plk) docks with prospective sub-
petuation of genetic errors, depending on the circum- strates by a phosphorylation-mediated mechanism (Elia
stances. et al., 2003). Plk contains a Polo-box domain (PBD) that
interacts with phosphorylated sequences in substrates
such as Cdc25C. We investigated whether phosphoryla-Results
tion of Claspin is necessary for binding to Plx1 by mutat-
ing candidate serines and threonines in the region ofPlx1 Associates with Claspin in a Checkpoint-
Regulated Manner Claspin that is required for binding to Plx1 (residues
878–920) (Figure 2A). Since this region partially overlapsOur laboratory has been interested in the function and
regulation of Plx1 in Xenopus egg extracts, especially the previously identified Chk1 binding domain (CKBD)
of Claspin at residues 847–903, in which we had alreadyduring checkpoint responses. For these studies, we
searched for Plx1-interacting proteins by immunopreci- prepared a number of Ser/Thr to Ala mutations (Kumagai
and Dunphy, 2003), we also examined these sites. Ini-pitating Plx1 from egg extracts (Figure 1A). Two closely
spaced bands at approximately 180 kDa attracted our tially, we examined mutations that were introduced into
the Claspin(776–1174) fragment, which binds well toattention, because the pattern of these proteins
changed subtly after treatment with pA-pT (not shown), Plx1. None of the mutations in the CKBD affected bind-
ing to Plx1 (Figure 2B). For example, the 2AG mutant,suggesting that there is some change in state of modifi-
cation or abundance among these proteins in the immu- which lacks S864 and S895 and thus cannot bind to
Xchk1, interacts normally with Plx1. By contrast, a qua-noprecipitates upon checkpoint activation. Mass spec-
trometric analysis indicated that these bands contain druple mutant of Claspin(776–1174) lacking S905, T906,
S909, and S910 was unable to associate with Plx1 (Fig-multiple polypeptides, including Claspin (see Experi-
mental Procedures). ure 2C). Upon further analysis, we observed that a single
point mutant of Claspin(776–1174) in which T906 wasTo assess the specificity of the interaction between
Plx1 and Claspin, we performed reciprocal immunopre- changed to alanine (T906A) also could not interact with
Plx1. By comparison, a single S910A mutant could stillcipitation experiments. First, we immunoprecipitated
Plx1 from interphase extracts, M phase extracts, and bind to Plx1.
We proceeded to introduce the T906A mutation intointerphase extracts containing pA-pT and then per-
formed immunoblotting with anti-Claspin antibodies the full-length Claspin protein. As shown in Figure 3A,
35S-labeled Claspin-T906A displayed only background(Figure 1B). We observed similar amounts of Claspin in
anti-Plx1 immunoprecipitates from interphase and M levels of binding to Plx1. We also prepared a full-length
version of His6-Claspin-T906A in baculovirus-infectedphase extracts, but there was highly elevated binding
of Claspin to Plx1 in extracts containing pA-pT. Con- insect cells. Next, we removed the endogenous Claspin
from egg extracts by immunodepletion with anti-Claspinversely, we also detected Plx1 in anti-Claspin immuno-
precipitates by immunoblotting with anti-Plx1 antibod- antibodies and subsequently replaced this protein with
either wild-type His6-Claspin or the His6-Claspin-T906Aies (Figure 1C). We likewise observed enhanced binding
of Plx1 to Claspin in the presence of pA-pT by this mutant (Figure 3B). Wild-type His6-Claspin bound well
to exogenously added Plx1-N172A-GH, but there wasmethod. Finally, we performed pull-down experiments
with a recombinant, kinase-inactive version of Plx1 no binding of His6-Claspin-T906A (Figure 3C).
Mechanism of Checkpoint Adaptation
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Figure 1. Claspin Interacts Specifically with
Plx1
(A) Control (lane 1) and anti-Plx1 (lane 2) im-
munoprecipitates from interphase egg ex-
tracts containing pA-pT were subjected to
SDS-PAGE and silver staining. Two bands at
approximately 180 kDa (corresponding to
those marked with arrowheads in top panel)
were excised from another, large-scale prep-
aration for mass spectrometry (see Experi-
mental Procedures). The upper band con-
tained Claspin. The bottom panel depicts the
area of the gel containing Plx1.
(B) Interphase extracts (lane 2), M phase ex-
tracts (lane 3), and interphase extracts con-
taining pA-pT (lanes 1 and 4) were immuno-
precipitated with control (lane 1) or anti-Plx1
antibodies (lanes 2–4). Immunoprecipitates
were immunoblotted for Claspin.
(C) Extracts containing no DNA (lane 2) or pA-
pT (lanes 1 and 3) were immunoprecipitated
with control (lane 1) or anti-Claspin antibodies
(lanes 2 and 3). Immunoprecipitates were im-
munoblotted for Plx1.
(D) Plx1-N172A-GH on nickel beads was incu-
bated in extracts containing no DNA (lane 1),
pA-pT (lane 2), or pA-pT plus caffeine (lane
3). The beads were reisolated and immuno-
blotted for Claspin.
(E) 35S-Labeled Claspin(1–744) (lanes 1–4),
Claspin(776–1285) (lanes 5–8), and Claspin
(776–1174) (lanes 9–12) were incubated in ex-
tracts containing Plx1-N172A-GH on nickel
beads in the absence (lanes 1, 3, 5, 7, 9, and
11) or presence of pA-pT (lanes 2, 4, 6, 8,
10, and 12). The beads were reisolated, and
bound 35S-labeled proteins were detected by
SDS-PAGE and phosphorimaging (lanes 3, 4,
7, 8, 11, and 12). Lanes 1, 2, 5, 6, 9, and 10
depict initial extract aliquots.
(F) Abilities of the indicated fragments of
Claspin to interact with Plx1.
To establish explicitly that T906 undergoes phosphor- lished for the recognition of Plk substrates by the PBD,
which is Ser-(pThr/pSer)-(Pro/X) (Elia et al., 2003). Inylation in egg extracts, we prepared antibodies against
a synthetic peptide from Claspin that contains phos- a sequence alignment, human Claspin also contains a
related motif (ST955P) in a similar location (Figure 3D).phorylated T906 (anti-P-T906) (see Figure 3D). As shown
in Figures 3E and 3F, the anti-P-T906 antibodies reacted The PBD of Plx1 lies in its C-terminal regulatory region
(amino acids 316–598). To evaluate whether this regionwell with both GST-Claspin(878–962) and full-length
His6-Claspin that had been incubated in extracts in the interacts with phosphorylated Claspin, we prepared re-
combinant forms of the N-terminal and C-terminal do-presence but not the absence of pA-pT. The anti-P-T906
antibodies did not recognize T906A mutant versions of mains of Plx1, which we named N-Plx1-GH and C-Plx1-
GH, respectively (see Figure 3G). As depicted in Figurethese polypeptides. Furthermore, treatment with caf-
feine abolished the reactivity of Claspin with the anti-P- 3H, Claspin bound well to full-length Plx1-GH and
C-Plx1-GH but not to N-Plx1-GH or a control His6-GSTT906 antibodies. Taken together, these results establish
that phosphorylation of T906 in Claspin is essential for protein. These results, along with the known specificity
of the PBD, suggest strongly that T906-phosphorylatedthe binding of Plx1. Significantly, the sequence con-
taining this residue (ST906Q) fits the consensus estab- Claspin interacts with the PBD of Plx1.
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Figure 2. T906 of Claspin Is Required for
Binding to Plx1
(A) Mutants of Claspin(776–1174) used for the
Plx1 binding studies.
(B) 35S-Labeled 2AG, 2AQ, and 6A mutants
were analyzed for binding to Plx1 as de-
scribed in Figure 1E.
(C) 35S-Labeled AAAA, T906A, and S910A mu-
tants were analyzed for binding to Plx1.
Phosphorylation of T906 on Claspin Is Checkpoint aged chromatin, which also accumulates replication
blocks. By contrast, Claspin from control extracts didRegulated and Depends upon ATR
Thus far, we have shown that the DNA template pA-pT not react with the anti-P-T906 antibodies.
To investigate whether Claspin and Plx1 also form astimulates the binding of Plx1 to Claspin. In Xenopus
egg extracts, this template can trigger the phosphoryla- complex in the presence of aphidicolin-induced replica-
tion blocks, we extracted Claspin from chromatin frac-tion of both Xchk1 and Xchk2, the Xenopus homolog of
Chk2 (Guo and Dunphy, 2000; Kumagai and Dunphy, tions with 0.5 M NaCl and then immunoprecipitated the
salt eluates with anti-Plx1 antibodies. We found that2000). In general, Xchk1 is activated primarily in re-
sponse to DNA replication blocks. By contrast, the activ- Claspin was present in the anti-Plx1 immunoprecipitates
from aphidicolin-treated chromatin but not in immuno-ity of Xchk2 is increased by the presence of double-
stranded DNA breaks. precipitates from samples that lacked aphidicolin or
contained aphidicolin plus caffeine (Figure 4B). TheseTo examine the relationship between Claspin and Plx1
during a checkpoint response to stalled replication forks results suggest that Plx1 associates with Claspin at
stalled replication forks.in chromosomal DNA, we added demembranated sperm
nuclei and aphidicolin to egg extracts. After 100 min, We also asked what kinase regulates phosphorylation
of Claspin on T906. Xatr seemed a plausible candidatewe isolated chromatin fractions from the extracts and
performed immunoblotting with antibodies against because phosphorylation on T906 increases in the pres-
ence of DNA replication blocks, and the sequenceClaspin, P-T906 of Claspin, and Xorc2 (to monitor recov-
ery of chromatin) (Figure 4A). As described previously, around T906 resembles a consensus site for ATR. We
found that the aphidicolin-dependent phosphorylationClaspin binds in elevated amounts to aphidicolin-
treated chromatin (Lee et al., 2003). The Claspin that of Claspin on T906 was abolished in the Xatr-depleted
extracts (Figures 4C and 4D). Therefore, it appears thathad associated with chromatin in aphidicolin-treated
extracts reacted strongly with the anti-P-T906 antibod- Xatr or some Xatr-dependent kinase phosphorylates
T906. Taken together, these results suggest that theies. Likewise, T906 became phosphorylated on UV-dam-
Mechanism of Checkpoint Adaptation
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Figure 3. Phosphorylation of Claspin on
T906 Is Required for Binding to Plx1
(A) Binding of 35S-labeled full-length Claspin
(lanes 1–4) and Claspin-T906A (lanes 5–8) to
recombinant Plx1 was determined in the ab-
sence (lanes 1, 3, 5, and 7) or presence of
pA-pT (lanes 2, 4, 6, and 8).
(B) Egg extracts were mock depleted with
control antibodies (lane 1) or immunode-
pleted with anti-Claspin antibodies (lanes
2–4). Subsequently, no recombinant protein
(lane 2), wild-type His6-Claspin (lane 3), or
His6-Claspin-T906A (lane 4) was added back
to the depleted extracts. Extracts were immu-
noblotted for Claspin.
(C) Mock-depleted (lanes 1 and 2) and
Claspin-depleted extracts containing His6-
Claspin (lanes 3 and 4) or His6-Claspin-T906A
(lanes 5 and 6) were incubated with Plx1-
N172A-GH in the absence (lanes 1, 3, and 5)
or presence of pA-pT (lanes 2, 4, and 6). Plx1-
N172A-GH was reisolated with glutathione
beads, and bound Claspin was detected by
immunoblotting. Plx1 was stained with Coo-
massie blue.
(D) Alignment of residues 900–910 from Xeno-
pus Claspin with human Claspin.
(E) Specificity of anti-P-T906 antibodies. Inter-
phase extracts containing no DNA (lanes 1 and
4), pA-pT (lanes 2 and 5), or pA-pT plus caffeine
(lane 3) were incubated with GST-Claspin(878–
962) (lanes 1–3) or GST-Claspin(878–962)-T906A
(lanes 4 and 5). The GST-tagged fragments
were reisolated with glutathione beads, sub-
jected to SDS-PAGE, and either immunoblot-
ted with anti-P-T906 antibodies (top) or stained
with Coomassie brilliant blue (CBB) (bottom).
(F) His6-Claspin (lanes 1 and 2) or His6-
Claspin-T906A (lanes 3 and 4) on nickel beads
was incubated in egg extracts in the absence
(lanes 1 and 3) or presence of pA-pT (lanes 2
and 4). His6-tagged proteins were reisolated
and immunoblotted with anti-P-T906 (top) or
anti-Claspin antibodies (bottom).
(G) Diagram of kinase and Polo-box domains
of Plx1.
(H) 35S-Claspin(776–1174) was incubated in extracts containing control His6-GST protein (HG) (lanes 3 and 4), full-length Plx1-GH (lanes 5 and
6), N-Plx1-GH (lanes 7 and 8), or C-Plx1-GH (lanes 9 and 10) in the absence (lanes 1, 3, 5, 7, and 9) or presence of pA-pT (lanes 2, 4, 6, 8,
and 10). The beads were reisolated, and binding of radiolabeled Claspin was determined. Lanes 1 and 2 depict initial extract aliquots.
Xatr-dependent phosphorylation of Claspin on T906 re- from M phase extracts. By contrast, the activity of Plx1
in interphase extracts did not increase in the presencecruits Plx1 to chromatin during a DNA replication check-
point response in egg extracts. of cycloheximide, which prevents the synthesis of cyclin
B. In conclusion, it appears that Plx1 is not kept inactive
in the presence of incompletely replicated DNA.Claspin Appears Not to Be Involved in Negative
Regulation of Plx1 We also examined the activity of Plx1 in extracts con-
taining pA-pT (Figure 4E). We observed that pA-pTIn order to evaluate the functional significance of the
interaction between Claspin and Plx1, we considered blocked the activation of Plx1 very efficiently, which is
consistent with reports that double-stranded DNA endsvarious models. For example, Claspin could be involved
in the negative regulation of Plx1. In this case, one might downregulate Plk1 in irradiated human cells (Smits et
al., 2000). These observations raised the possibility thatpredict that Plx1 would be downregulated in check-
point-activated egg extracts. To examine this issue, we Claspin might be necessary for the negative regulation
of Plx1 in response to double-stranded DNA ends. How-isolated Plx1 at various times from interphase extracts
lacking or containing aphidicolin and assayed kinase ever, we found that Plx1 is still downregulated efficiently
by the presence of pA-pT in Claspin-depleted egg ex-activity toward Cdc25C. We observed that the kinase
activity of Plx1 increased steadily in both the absence tracts (data not shown). Taken together, these various
observations make it seem unlikely that binding ofand presence of aphidicolin (Figure 4E). By 100 min, the
activity of Plx1 in both cases approached that of Plx1 Claspin to Plx1 reflects negative regulation of Plx1. Inter-
Cell
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for Plx1. We observed that full-length His6-Claspin un-
derwent significant phosphorylation upon incubation
with 32P-ATP and anti-Plx1 immunoprecipitates from M
phase extracts of Xenopus eggs (data not shown). In
mapping experiments, GST peptides containing amino
acids 847–962 and 878–962 of Claspin served as excel-
lent substrates for immunoprecipitated Plx1 (Figure 5A).
By contrast, GST-Claspin(847–920) did not become
phosphorylated in this assay, which suggests that resi-
dues 921–962 contain a phosphorylation site(s) for Plx1.
We also found that recombinant wild-type Plx1 but not
the kinase-inactive Plx1-N172A mutant could phosphor-
ylate the GST-Claspin(847–962) substrate efficiently
(Figure 5B). Consistent with the results described above,
recombinant Plx1 did not phosphorylate the GST-
Claspin(847–920) peptide.
In the 921–962 region of Claspin, the sequence con-
taining S934 resembles a consensus Plk phosphorylation
site (Nakajima et al., 2003). We prepared a version of GST-
Claspin(847–962) in which S934 was changed to alanine.
As shown in Figure 5C, GST-Claspin(847–962)-S934A
could not function as a substrate for Plx1. We performed
tryptic phosphopeptide mapping to establish that S934
becomes phosphorylated in egg extracts (see Supple-
mental Figure S1 at http:/www.cell.com/cgi/content/
full/117/5/575/DC1). We also prepared anti-phospho-
peptide antibodies against an S934-phosphorylated
peptide from Claspin (anti-P-S934). These anti-P-S934
antibodies reacted well with Claspin in aphidicolin-
Figure 4. Characterization of the Claspin-Plx1 Interaction in Aphidi- treated extracts (Figure 5D). Furthermore, immunode-
colin-Containing Extracts pletion of Plx1 abolished the reactivity of Claspin with
(A) Extracts were incubated for 100 min with 1000 sperm nuclei/l the anti-P-S934 antibodies.
alone (lane 1), sperm nuclei plus aphidicolin (APH) (lane 2), or UV- These results indicate that Plx1 phosphorylates
damaged sperm nuclei (lane 3). Chromatin fractions were isolated
Claspin on S934, which is relatively close to the Plx1-and immunoblotted with anti-Claspin, anti-P-T906, and anti-Xorc2
docking site at T906. Human Claspin also contains aantibodies.
serine at position 984 in a homologous sequence (Figure(B) Extracts were incubated for 100 min with no drug (lane 2), aphidi-
colin (lanes 1 and 3), or aphidicolin plus caffeine (lane 4). Chromatin 5F). As one step to evaluate whether phosphorylation
fractions were isolated and extracted with 0.5 M NaCl. Control (lane of Claspin on T906 facilitates phosphorylation of S934
1) and anti-Plx1 (lanes 2–4) immunoprecipitates from salt eluates by Plx1, we performed a time course experiment. For
were immunoblotted for Claspin.
this purpose, we immunoblotted chromatin fractions(C) Immunodepletion of Xatr. Extracts were treated with control (lane
from egg extracts at different times with anti-P-T9061) or anti-Xatr antibodies (lane 2) and immunoblotted for Xatr. Lane
and anti-P-S934 antibodies (Figure 5E). The results dem-3 shows untreated extract.
(D) The indicated extracts from (C) were incubated in the absence onstrated that phosphorylation of T906 significantly pre-
(lane 1) or presence of aphidicolin (lanes 2–4). Nuclear fractions cedes phosphorylation of S934.
were isolated and immunoblotted with anti-Claspin, anti-P-T906,
and anti-Xorc2 antibodies.
The T906A and S934A Mutants of Claspin Are(E) Kinase activity of Plx1 in checkpoint-activated extracts. M phase
Defective in Checkpoint Adaptationextracts from cytostatic factor (CSF)-arrested eggs were activated
with calcium and incubated with no further addition (top), 1000 In order to explain the interaction between Plx1 and
sperm nuclei/l and 100g/ml aphidicolin, 100g/ml cycloheximide Claspin, we considered the possibility that Plx1 could
(CHX), or 50 g/ml pA-pT. At the indicated times, Plx1 was immuno- negatively regulate Claspin, for example, by promoting
precipitated and assayed for kinase activity by 32P incorporation
the termination of a checkpoint arrest. Typically, controlinto His6-Cdc25(1-264) as described in Supplemental Data.
egg extracts enter mitosis after approximately 90–120
min of incubation. By contrast, in the presence of aphidi-
colin, the egg extracts remain arrested in interphaseestingly, however, Plx1 responds differently to DNA rep-
lication blocks versus double-stranded DNA ends. for at least 180 min. Nonetheless, aphidicolin-treated
extracts also eventually undergo mitosis. Typically, this
process begins at approximately 180–210 min. This ap-Plx1 Phosphorylates Claspin on S934
The docking of Plx1 onto Claspin could facilitate the pears to be a genuine mitosis on the basis of several
criteria. There is a sharp rise in Cdc2-associated H1phosphorylation of Claspin by Plx1. Consistent with this
possibility, Plx1 is active in aphidicolin-treated extracts, kinase activity at this time (see below). Concomitantly,
Cdc25C undergoes the characteristic hyperphosphory-in which Plx1 binds well to Claspin. Therefore, we exam-
ined directly whether Claspin could serve as a substrate lation that is a marker for its activation at mitosis (data
Mechanism of Checkpoint Adaptation
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Figure 5. Plx1 Phosphorylates Claspin on
S934
(A) GST-Claspin(847–962) (lanes 1 and 2),
GST-Claspin(847–920) (lanes 3 and 4), and
GST-Claspin(878–962) (lanes 5 and 6) were
incubated with 32P-ATP and either control
(lanes 1, 3, and 5) or anti-Plx1 immunoprecipi-
tates (lanes 2, 4, and 6) from M phase ex-
tracts. GST-tagged fragments were stained
with Coomassie blue (bottom). Incorporation
of 32P was detected with a phosphorimager
(top).
(B) Plx1-GH (lanes 2 and 4) and Plx1-N172A-
GH (lanes 1 and 3) on nickel beads were incu-
bated in M phase egg extracts as described
in Supplemental Data. The beads were reiso-
lated and incubated with Claspin(847–962)
(lanes 1 and 2) or Claspin(847–920) (lanes 3
and 4) in the presence of 32P-ATP. Recombi-
nant Plx1 proteins (top) and GST-tagged
Claspin fragments (bottom) were stained with
Coomassie blue. Incorporation of 32P was de-
tected with a phosphorimager (middle).
(C) GST-Claspin(847–962) (lanes 1 and 2) and
GST-Claspin(847–962)-S934A (lanes 3 and 4)
were incubated in the presence of 32P-ATP
with control (lanes 1 and 3) or anti-Plx1 immu-
noprecipitates (lanes 2 and 4) from M phase
extracts. GST-Claspin fragments were stained
with Coomassie blue (bottom). Incorporation
of 32P was detected with a phosphorimager
(top).
(D) Effect of immunodepletion of Plx1 on
phosphorylation of S934. Egg extracts were
treated with control antibodies (lane 1), anti-
Plx1 antibodies (lane 2), or no antibodies (lane
3) and incubated with sperm nuclei and
aphidicolin for 120 min. Extracts were immu-
noblotted for Plx1 (top panel). Nuclear frac-
tions were isolated and immunoblotted with
anti-Claspin, anti-P-S934, and anti-Xorc2 anti-
bodies (bottom three panels).
(E) Time courses for phosphorylation on T906
and S934. Chromatin fractions were isolated
from aphidicolin-treated extracts at the times
shown and immunoblotted with anti-Claspin,
anti-P-T906, anti-P-S934, and anti-Xorc2 anti-
bodies.
(F) Alignment of residues 929–937 from Xeno-
pus Claspin with human Claspin.
not shown). Finally, the condensed chromatin that forms For the first 150–180 min, the mock-depleted extracts,
as well as Claspin-depleted extracts containing His6-in such extracts is morphologically very similar to the
chromatin in mitotic extracts that had never been ex- Claspin, His6-Claspin-T906A, or Claspin-S943A, all be-
haved similarly. In particular, these extracts all arrestedposed to aphidicolin (data not shown).
In order to assess whether regulation of Claspin by in interphase, which indicates that a checkpoint-induced
delay of the cell cycle had been triggered successfully.Plx1 is involved in adaptation of the DNA replication
checkpoint, we first removed the endogenous Claspin For comparison, mock-depleted extracts lacking aphidi-
colin underwent NEB at 100–120 min. Therefore, thefrom egg extracts by immunodepletion with anti-Claspin
antibodies (Figures 6A and 6B). In parallel, we prepared T906A and S934A mutants are proficient at triggering a
checkpoint delay. Consistent with this observation, wemock-depleted extracts by using control antibodies.
Next, we added back wild-type His6-Claspin, His6- observed that Xchk1 underwent checkpoint-dependent
phosphorylation normally in extracts containing theClaspin-T906A, or His6-Claspin-S934A to the Claspin-
depleted extracts at very similar concentrations. Finally, T906A and S934A mutants (data not shown; also see
Figure 7). However, the various aphidicolin-treated ex-we added sperm chromatin and aphidicolin to the ex-
tracts and monitored nuclear envelope breakdown tracts displayed different behaviors at later times. We
observed that mock-depleted extracts and Claspin-(NEB) as an indicator for mitosis.
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Figure 6. Egg Extracts Containing the T906A
and S934A Mutants of Claspin Are Defective
for Checkpoint Adaptation
(A) Extracts were subjected to mock immuno-
depletion (open circles and closed circles) or
immunodepletion of Claspin (open triangles,
closed triangles, and open squares). His6-
Claspin (open triangles), His6-Claspin-T906A
(closed triangles), and His6-Claspin-S934A
(open squares) were added back to the
Claspin-depleted extracts. The extracts were
incubated with sperm nuclei in the absence or
presence of aphidicolin, as indicated. Nuclear
envelope breakdown (NEB) was determined
at the indicated times by microscopy.
(B) Anti-Claspin immunoblots of extracts
used for the experiment in Figure 6A. Mock-
depleted (lane 1) and Claspin-depleted ex-
tracts containing no added protein (lane 2),
His6-Claspin (lane 3), His6-Claspin-T906A
(lane 4), and His6-Claspin-S934A (lane 5)
were immunoblotted with anti-Claspin anti-
bodies.
(C) Assay of Cdc2-associated H1 kinase ac-
tivity. Aliquots from mock-depleted (top) and
Claspin-depleted extracts containing either
His6-Claspin (middle) or His6-Claspin-T906A
(bottom) were removed at the indicated times
and incubated with histone H1 and 32P-ATP.
Incorporation of 32P was detected with a
phosphorimager.
(D) Quantitation of H1 kinase activity from Fig-
ure 6C (in arbitrary units).
depleted extracts containing wild-type His6-Claspin (data not shown). Upon further examination, we found
that the NEB that occurs at later times in extracts con-underwent NEB at 210–240 min. By contrast, the timing
of NEB was significantly delayed in extracts containing taining the T906A and S934A mutants is due to the
occurrence of apoptosis rather than entry into mitosisthe His6-Claspin-T906A or His6-Claspin-S934A mu-
tants. (data not shown). Apoptosis also occurs in untreated
extracts lacking aphidicolin with similar timing, whichIn order to pursue these observations further, we also
measured phosphorylation of histone H1 as a marker has been well documented (Newmeyer et al., 1994).
Therefore, it is unclear whether there is a connectionfor Cdc2-associated kinase activity. As shown in Figures
6C and 6D, there was also a steep rise in H1 kinase between failure of adaptation and occurrence of apopto-
sis. Taken together, these results indicate that extractsactivity at 210–240 min coincident with NEB in mock-
depleted extracts and Claspin-depleted extracts con- containing the T906A and S934A mutants of Claspin are
unable to undergo adaptation and entry into mitosistaining wild-type His6-Claspin, both of which were
treated with aphidicolin. However, there was no rise in after a prolonged checkpoint arrest. Eventually, the nu-
clei in extracts containing these mutants do undergoH1 kinase activity even by 300 min in aphidicolin-treated
extracts containing the T906A mutant (Figures 6C and breakdown, but this process represents apoptotic disin-
tegration and not mitotic disassembly.6D). We obtained similar results for the S934A mutant
Mechanism of Checkpoint Adaptation
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Figure 7. The T906A and S934A Mutants of
Claspin Display Elevated Binding to Aphidi-
colin-Treated Chromatin
(A) Claspin is present in low amounts on
chromatin at M phase. At the indicated
times, chromatin fractions were isolated
from extracts lacking cycloheximide and im-
munoblotted for Claspin (top) and Xorc2 (bot-
tom). This extract entered mitosis at 105–
120 min.
(B) Interphase extracts were incubated with
cycloheximide for 60 min, and then buffer
(lane 1) or human His6-cyclin B1 (lane 2) was
added. After 10 min (when mitosis had oc-
curred in the cyclin-treated extract), chroma-
tin fractions were isolated and immunoblot-
ted for Claspin (top) and Xorc2 (bottom).
(C) Chromatin binding properties of mutant
Claspin proteins. Egg extracts were treated
with control (lane 1) or anti-Claspin antibodies
(lanes 2–5). To the Claspin-depleted extracts,
no recombinant protein (lane 2), wild-type
His6-Claspin (lane 3), His6-Claspin-T906A
(lane 4), and His6-Claspin-S934A (lane 5)
were added back. Aliquots of the extracts
were immunoblotted for Claspin (top). These
extracts were incubated for 100 min. At this
time, chromatin fractions were isolated and
immunoblotted with anti-Claspin, anti-P-S934,
and anti-Xorc2 antibodies (bottom three
panels).
(D) Immunodepletion of Plx1. Egg extracts
were treated with control (lane 1) or anti-Plx1
antibodies (lanes 2 and 3). Recombinant
Plx1-GH was added back to an aliquot of
Plx1-depleted extract (lane 3). The extracts
were immunoblotted for Plx1.
(E) Binding of Claspin to chromatin in Plx1-
depleted extracts. Mock-depleted extracts
(lanes 1 and 2), Plx1-depleted extracts (lanes
3 and 4), and Plx1-depleted extracts con-
taining Plx1-GH (lanes 5 and 6) from panel D
were incubated for 100 min in the absence
(lanes 1, 3, and 5) or presence of aphidicolin
(lanes 2, 4, and 6). Chromatin fractions were
isolated and immunoblotted for Claspin (top)
and Xorc2 (bottom).
(F) Mock-depleted extracts (lanes 1–3),
Claspin-depleted extracts containing His6-
Claspin (lanes 4–6), and Claspin-depleted ex-
tracts containing His6-Claspin-T906A (lanes 7–9) were incubated with sperm nuclei and aphidicolin. In addition, mock-depleted extracts were
incubated with UV-damaged sperm chromatin (lanes 10–12). At the indicated times, chromatin fractions were isolated and immunoblotted for
Claspin (top panel), Xorc2 (second panel from top), and the p70 subunit of Pol  (third panel from top). For the experiment in the bottom
panel, 35S-labeled Xchk1-KD was synthesized in the TnT system, separated from unincorporated 35S methionine by gel filtration, and added
to the indicated extracts. At the times shown, whole extracts were subjected to SDS-PAGE, and the electrophoretic mobility of 35S-Xchk1-
KD was assessed by phosphorimaging.
(G) Immunodepletion of Plx1 prevents adaptation. Mock-depleted (lanes 1–3) and Plx1-depleted extracts (lanes 4–6) were treated with
aphidicolin. At the indicated times, binding of Claspin, Xorc2, and Pol  to chromatin and phosphorylation of 35S-Xchk1-KD in whole extracts
were determined as in Figure 7F.
The T906A and S934A Mutants of Claspin Display presence of cycloheximide, which blocks the entry into
mitosis. Cycloheximide inhibits the synthesis of cyclinEnhanced Binding to Aphidicolin-Treated Chromatin
To investigate the mechanism by which Plx1 might con- B and also prevents the activation of Plx1 (Figure 4E).
For this reason, we initially characterized the bindingtrol Claspin during checkpoint adaptation, we examined
whether regulation by Plx1 affects the chromatin binding of Claspin to chromatin in extracts that proceed into
mitosis. First, we examined binding in extracts that didproperties of Claspin. As described previously, Claspin
binds to chromatin during a normal S phase in Xenopus not contain either cycloheximide or aphidicolin (Figure
7A). Consistent with previous findings, binding ofegg extracts in a manner that requires the pre-RC,
Cdc45, and Cdk2 (Lee et al., 2003). This binding in- Claspin to chromatin peaked at 40–60 min and then
declined as DNA replication approached completion. Atcreases substantially in the presence of aphidicolin. All
of these previous experiments were performed in the 120 min, when this particular extract had entered mito-
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sis, there was relatively little Claspin on chromatin. In and Claspin-depleted extracts containing wild-type
another type of experiment, we incubated chromatin in His6-Claspin, the aphidicolin-induced phosphorylation
egg extracts containing cycloheximide for 60 min and of Xchk1-KD was reversed. By contrast, in Claspin-
then added a high concentration of recombinant human depleted extracts containing the T906A mutant, Xchk1-
His6-cyclin B1, which induced mitosis in 5–10 min. We KD remained in its hyperphosphorylated form at 240
observed that addition of cyclin B1 triggered the release min. As a control, we showed that, in the absence of
of Claspin from chromatin (Figure 7B). Altogether, these aphidicolin, Xchk1-KD does not undergo phosphoryla-
results indicate that there is little if any Claspin on chro- tion in extracts containing either the T906A or S934A
matin at mitosis when Cdc2-cyclin B and Plx1 are maxi- mutants (see Supplemental Figure S2 on Cell website).
mally active. This observation argues that the T906A and S934A mu-
We proceeded to evaluate whether Plx1 affects the tants do not prolong a checkpoint response by dis-
binding of Claspin to chromatin during an aphidicolin- rupting replication forks.
induced arrest. To examine this possibility, we first A significant consideration in these experiments is
immunodepleted the endogenous Claspin from egg ex- whether the initiating checkpoint signal, namely aphidi-
tracts and replaced it with wild-type His6-Claspin, His6- colin-induced DNA replication blocks, is still present at
Claspin-T906A, or His6-Claspin-S934A (Figure 7C). the time of adaptation. We ruled out the trivial possibility
Next, we added sperm chromatin and aphidicolin to the that aphidicolin loses efficacy at later times by showing
various extracts. Finally, we reisolated chromatin from that there is no measurable DNA synthesis at 240 min
the extracts after 100 min and performed immunoblot- in aphidicolin-treated extracts (data not shown). We also
ting with anti-Claspin antibodies (Figure 7C). As ex- assessed the presence of stalled replication forks by
pected, we could readily detect Claspin on aphidicolin- immunoblotting chromatin fractions for Pol , which ac-
treated chromatin from mock-depleted extracts and cumulates in high amounts at stalled forks in aphidi-
Claspin-depleted extracts containing wild-type His6- colin-treated chromatin (Walter and Newport, 2000). Al-
Claspin. However, there was highly elevated binding though there was some reduction at later times, the
of both the T906A and S934A mutants of Claspin to results showed that, at 240 min, Pol  remained in sub-
chromatin under these conditions. We also examined stantial amounts on chromatin from mock-depleted ex-
the chromatin fractions by immunoblotting with anti- tracts and Claspin-depleted extracts containing either
S934-P antibodies. These antibodies reacted well with wild-type His6-Claspin or the Claspin-T906A mutant
endogenous Claspin and wild-type His6-Claspin. By (Figure 7F). Thus, there appears not to be a general
comparison, the anti-P-S934 antibodies interacted collapse of stalled DNA replication forks at this time.
weakly with the chromatin bound His6-Claspin-T906A Extracts containing UV-damaged chromatin also un-
mutant (note that amount of His6-Claspin-T906A on dergo adaptation by 240 min, as indicated by dissocia-
chromatin greatly exceeds that of wild-type His6- tion of Claspin from chromatin, inactivation of Xchk1,
Claspin). These observations imply that phosphorylation and persistence of Pol  on the DNA (Figure 7F). There-
of Claspin on T906 facilitates subsequent phosphoryla- fore, adaptation of the checkpoint response to DNA
tion of S934. replication blocks occurs whether these blocks accu-
These findings suggest that Plx1 might negatively reg- mulate because of treatment with aphidicolin or infliction
ulate the association of Claspin with chromatin. To in- of UV damage.
vestigate this possibility further, we removed Plx1 from Finally, we also assessed the role of Plx1 in adaptation
egg extracts with anti-Plx1 antibodies (Figure 7D). We by immunodepleting this kinase from the extracts. As
could restore Plx1 by adding back a recombinant Plx1- shown in Figure 7G, Claspin remained on chromatin,
GH protein. As shown in Figure 7E, immunodepletion of and Xchk1 did not undergo inactivation at 240 min in
Plx1 resulted in enhanced binding of Claspin to chroma- Plx1-depleted extracts containing aphidicolin. Overall,
tin in both the absence and presence of aphidicolin.
these results suggest that Plx1 promotes both the disso-
Furthermore, this increase was abrogated by the addi-
ciation of Claspin from chromatin and inactivation of
tion of recombinant Plx1-GH back to the Plx1-depleted ex-
Xchk1 in aphidicolin-treated extracts that undergo ad-tracts.
aptation after a prolonged interphase arrest. This pro-Next, we examined the binding of Claspin to chroma-
cess corresponds to adaptation rather than recovery,tin as a function of time in aphidicolin-treated extracts
because stalled replication forks persist upon mitoticundergoing adaptation. As shown in Figure 7F, the
entry.amount of endogenous Claspin on chromatin in mock-
depleted extracts declined at 180–240 min as these ex-
tracts underwent adaptation. A similar decrease oc-
Discussioncurred around the same time for wild-type His6-Claspin
that had been added back to Claspin-depleted extracts.
Signal transduction pathways commonly undergo adap-By contrast, the His6-Claspin-T906A mutant remained
tation in the continued presence of an activating signalassociated with chromatin at high levels during this pe-
or ligand. In this report, we have found that the DNAriod. In parallel, we also examined the checkpoint-
replication checkpoint response in Xenopus egg ex-dependent phosphorylation of Xchk1 (Figure 7F). For
tracts eventually undergoes adaptation, so that bio-this purpose, we monitored the electrophoretic mobility
chemical events of mitosis occur despite the presenceof a 35S-labeled form of the Xchk1-KD protein (Michael
of incompletely replicated DNA. This process dependset al., 2000), whose phosphorylation can be detected in
upon Plx1, which negatively regulates Claspin, a criticalwhole egg extracts without the need for isolation of
nuclear fractions. At 240 min, in both mock-depleted mediator of the DNA replication checkpoint (see Figure
Mechanism of Checkpoint Adaptation
585
phosphatase is unknown, but our data argue that this
enzyme is either constitutively active or subject to nega-
tive regulation by the Claspin-dependent pathway.
Claspin accumulates on chromatin at high levels when
control by Plx1 is compromised. One model would be
that phosphorylation of Claspin by Plx1 lowers its affinity
for chromatin and that dissociation of Claspin from the
replication fork consequently leads to ablation of check-
point signaling. Another possibility is that Plx1 inacti-
vates Claspin by some other mechanism—for example,
by inhibiting its ability to mediate Xatr-dependent activa-
tion of Xchk1. In this case, Claspin may dissociate from
chromatin as a result of abolished checkpoint signaling.
The fact that adaptation appears to lag behind phos-
phorylation on S934 suggests that some additional
step(s) is involved in this process.
According to the definition of checkpoint adaptation
(Sandell and Zakian, 1993; Toczyski et al., 1997), a
checkpoint-inducing signal should be present at the
time that arrest of the cell cycle is alleviated. Therefore, a
significant consideration is whether aphidicolin-induced
DNA replication blocks remain at the time that Plx1 pro-
motes mitotic entry. Pol  remains associated in large
amounts with chromatin at the time of adaptation, which
argues that this process is not due to a general collapse
of DNA replication forks. It remains possible that there
is some less drastic alteration of replication forks that
compromises checkpoint signaling at this time. None-
theless, since extracts containing the T906A and S934A
mutants of Claspin cannot enter mitosis, one would have
to argue that such an alteration could not occur in the
presence of these mutants. Interestingly, Mrc1, a Claspin
homolog, has been implicated in replication pausing in
budding yeast, which suggests that this protein regu-
lates the replication fork in some manner (Katou et al.,
2003). It is possible that Claspin could control the struc-
Figure 8. Model for Regulation of Claspin by Plx1 during a DNA ture of replication forks, in addition to its known function
Replication Checkpoint Response
in mediating the activation of Xchk1 by Xatr. If so, our
results would suggest that Plx1 negatively regulates the
ability of Claspin to control replication fork structure. In8). This regulation involves docking of Plx1 onto a phos-
this scenario, adaptation would occur because Claspinphopeptide motif in Claspin containing T906, which un-
cannot maintain the appropriate replication fork struc-dergoes phosphorylation during the course of the
ture for checkpoint signaling after phosphorylation bycheckpoint response. After docking, Plx1 phosphory-
Plx1.lates a nearby residue, namely S934, in Claspin. This
sequence of events leads to dissociation of Claspin from
chromatin, inactivation of Xchk1, and release of the cell Diverse Regulation of Plk
during Checkpoint Responsescycle arrest.
These studies have also provided additional insight into
the regulation of Plk during checkpoint responses. Hu-Targeting of a Checkpoint Mediator
Protein for Adaptation man Plk1 is downregulated in response to ionizing radi-
ation, which creates double-stranded DNA breaksClaspin is an attractive target for inactivation of a DNA
replication checkpoint response, because this protein (Smits et al., 2000). We have confirmed these observa-
tions in Xenopus egg extracts by showing that the freeis essential for imposition of this response. In principle,
there could be other targets of Plx1 as well as Plx1- double-stranded DNA ends inhibit activation of Plx1. By
contrast, substantial activation of Plx1 occurs in aphidi-independent mechanisms for checkpoint adaptation.
However, our observations appear to argue that Claspin colin-containing extracts. The effect of aphidicolin (or
hydroxyurea) on regulation of human Plk1 has not beenis the major if not exclusive target of this pathway. It is
difficult to envision how single point mutations in Claspin reported. It appears that aphidicolin can induce an in-
terphase arrest in egg extracts by triggering inhibition(e.g., T906A and S934A) would compromise the ability
of Plx1 to interact with other targets or affect Plx1- of the Cdc2-cyclin B pathway (and possibly one or more
other pathways) without shutting off the activation ofindependent mechanisms. Xchk1 undergoes dephos-
phorylation and inactivation when Claspin dissociates Plx1. It has been suggested that both active and inactive
Plk can dock onto prospective substrates by means offrom chromatin. The identity of the Xchk1-inactivating
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its PBD (Elia et al., 2003). In the latter case, such docking this case, targeting by Plk could inactivate putative
checkpoint mediator proteins that are involved in DNAmight promote the activation of inactive Plk. The fact
that Plx1 is already active in aphidicolin-treated extracts damage responses (e.g., 53BP1 and Mdc1) (reviewed
in Canman [2003]). Cells with extensive DNA damagewould likely enhance its ability to phosphorylate Claspin.
undergo apoptosis. The downregulation of checkpoint
mediator proteins could also help to determine the even-Adaptation in Other Systems and Contexts
tual fate of cells with damaged DNA.An important issue is whether the regulation of check-
point mediator proteins such as Claspin by Plk is con-
served in other systems. The budding yeast homolog Conclusion
of Plk is encoded by the CDC5 gene. Previous studies We have established that Plx1 negatively regulates the
have found that yeast cells harboring an allele of CDC5 checkpoint mediator protein Claspin during a DNA repli-
called cdc5-ad do not undergo adaptation of the DNA cation checkpoint response. As a consequence, Plx1
damage response (Toczyski et al., 1997). The budding triggers adaptation of the checkpoint arrest of the cell
yeast Cdc5-ad protein appears to have a very selective cycle, so that mitosis occurs despite the presence of
defect. For example, this protein is not compromised in incompletely replicated DNA. It will be important to eval-
general mitotic functions, because undamaged yeast uate whether such adaptive processes can lead to cell
cells containing this mutation appear to divide normally. death or genetic aberrations in multicellular organisms.
Furthermore, budding yeast cells with the cdc5-ad mu-
Experimental Procedurestation that have managed to repair damaged DNA also
recover normally from a checkpoint arrest and undergo
Xenopus Egg Extractsmitosis. The implication is that the Cdc5-ad protein has
Xenopus egg extracts were prepared as before (Kumagai and Dun-
some deficiency in interactions with the checkpoint con- phy, 2000). To induce checkpoint responses, extracts were incu-
trol machinery. By analogy with the studies in this paper, bated with 100g/ml aphidicolin in the presence of demembranated
sperm nuclei (1000–3000/l), sperm nuclei (1000–3000/l) irradiatedit is plausible that budding yeast Cdc5 may inactivate
with a UV dose of 1000 J/m2, or 50 g/ml pA-pT (Kumagai andthe checkpoint mediator protein Rad9. The downregula-
Dunphy, 2000). Methods for preparation of nuclear and chromatintion of Rad9 would be expected to lead to inactivation
fractions from extracts are described in Supplemental Data.of Rad53, which is known to occur during checkpoint
adaptation in this organism (Pellicioli et al., 2001).
Antibodies and Recombinant Proteins
In fission yeast, Crb2, a homolog of budding yeast The various antibodies used in this paper are described in Supple-
Rad9, is essential for the activation of Chk1 after DNA mental Data. Recombinant proteins were produced by expression
in baculovirus-infected insect cells or in vitro translation as de-damage. Crb2 is a substrate of Cdc2, the archetypal
scribed in Supplemental Data.cell cycle regulatory kinase (Esashi and Yanagida, 1999).
Fission yeast cells with a mutant of Crb2 lacking a certain
Immunoprecipitation and Immunodepletionphosphorylation site for Cdc2 (Crb2-T215A) cannot exit
For immunoprecipitations, extracts (100 l) were incubated witha DNA damage arrest properly. More recent studies have
Affiprep-protein A beads (Bio-Rad) containing 5 g of anti-Plx1 or
provided evidence that Cdc2 may regulate a repair func- anti-Claspin antibodies for 45 min at 4C. The beads were washed
tion of Crb2 during a G2 arrest (Caspari et al., 2002). three times with buffer A (10 mM HEPES-KOH [pH 7.5], 150 mM
NaCl, 0.5% NP-40, 2.5 mM EGTA, and 20 mM -glycerolphosphate)Notably, the sequences comprising the docking and
and once with HEPES-buffered saline (HBS; 10 mM HEPES-KOH [pHphosphorylation sites for Plx1 in Xenopus Claspin are
7.5], and 150 mM NaCl). For immunodepletion of Plx1, interphaseconserved in human Claspin. Treatment of mammalian
extracts (100 l) were incubated with 15 g of anti-Plx1 antibodiescells with aphidicolin or hydroxyurea leads to a pro-
bound to 10 l of Affiprep protein A beads at 4C for 45 min. After
longed S phase arrest. No clear evidence for adaptation the incubation, the beads were removed by centrifugation, and the
of this arrest has been provided, but this matter de- supernatants were treated for another round of depletion. Claspin
and Xatr were immunodepleted as described (Lee et al., 2003).serves further investigation. Aphidicolin-treated egg ex-
tracts that eventually undergo mitosis with stalled repli-
Identification of Plx1-Interacting Proteinscation forks would most likely experience the equivalent
by Mass Spectrometryof a mitotic catastrophe. A similar process in intact ani-
Anti-Plx1 immunoprecipitates were subjected to SDS-PAGE andmal cells would almost certainly ensure cell death. Under
stained with Coomassie blue. Two bands at approximately 180 kDa
such circumstances, adaptation may serve as a prelude were excised and in-gel digested with trypsin as described pre-
to cell death and elimination of defective cells from the viously (Shevchenko et al., 1996). Tryptic peptides were sequenced
by nanoelectrospray tandem mass spectrometry on a QSTAR Pulsarbody. It should also be noted that nearly complete inhibi-
i quadrupole time-of-flight mass spectrometer (MDS Sciex, Canada).tion of replication, as occurs following treatment with
Uninterpreted MS/MS spectra were first searched against a proteinaphidicolin, is not a situation that would normally be
sequence database MSDB by Mascot v.1.8 software (Matrix Scienceencountered in nature. It is conceivable that adaptation
Ltd., United Kingdom) installed on a local server. No restrictions on
in animal cells with less extensive blockage of replica- species of origin or protein molecular weight were imposed. All
tion, for example, following UV exposure, could result in Mascot hits were further verified by manual inspection of matched
tandem mass spectra. Spectra not matched by Mascot were manu-viable progeny with chromosomal aberrations. Although
ally interpreted de novo. The interpretation of each spectrum ren-such events could be quite rare, their occurrence might
dered a few degenerate, redundant, incomplete, and partly accuratebe very detrimental to an organism. Cells with impaired
candidate peptide sequences. All peptide sequence proposals ob-death capabilities may be more susceptible to such
tained by the interpretation of all tandem mass spectra were assem-
problems. bled into a single query, as described (Shevchenko et al., 2001),
A related question is whether Plk is involved in adapta- which was submitted to Mass Spectrometry-driven BLAST (MS
BLAST) (Shevchenko et al., 2003) search against a nonredundanttion of DNA damage responses in mammalian cells. In
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protein database nrdb95 on a web server at http://dove.embl- K.A. (2000). Xenopus ATR is a replication-dependent chromatin-
binding protein required for the DNA replication checkpoint. Curr.heidelberg.de/Blast2/msblast.html. Peptides from five proteins
along with a few peptides from rabbit IgG were identified in the two Biol. 10, 1565–1573.
bands. Three fragmented peptides exactly matched the corre- Jeong, S.Y., Kumagai, A., Lee, J., and Dunphy, W.G. (2003). Phos-
sponding peptide sequences from Xenopus Claspin. One additional phorylated Claspin interacts with a phosphate-binding site in the
peptide from Claspin was identified by sequence similarity because kinase domain of Chk1 during ATR-mediated activation. J. Biol.
of deamidation of asparagine. Five sequenced peptides enabled Chem. 278, 46782–46788.
crossspecies identification of a yet unknown Xenopus homolog of
Katou, Y., Kanoh, Y., Bando, M., Noguchi, H., Tanaka, H., Ashikari, T.,the transcription activator SNF2L4. Unknown Xenopus homologs
Sugimoto, K., and Shirahige, K. (2003). S-phase checkpoint proteinsof golgin-160 (nine matched peptides), polybromo-1/BAF180 (six
Tof1 and Mrc1 form a stable replication-pausing complex. Naturematched peptides), and a human hypothetical protein AK094821
424, 1078–1083.(one matched peptide) were also identified. We noted that, by com-
Kumagai, A., and Dunphy, W.G. (1996). Purification and molecularbining stringent (Mascot) and sequence similarity (MS BLAST) identi-
cloning of Plx1, a Cdc25-regulatory kinase from Xenopus egg ex-fication approaches, all fragmented peptide precursors were
tracts. Science 273, 1377–1380.matched, which ensured that no unknown Xenopus proteins were
missed. Kumagai, A., and Dunphy, W.G. (2000). Claspin, a novel protein
required for the activation of Chk1 during a DNA replication check-
Assay for Binding of Claspin Fragments point response in Xenopus egg extracts. Mol. Cell 6, 839–849.
to Plx1 in Egg Extracts Kumagai, A., and Dunphy, W.G. (2003). Repeated phosphopeptide
Recombinant Plx1 (2 g) bound to nickel agarose beads (10 l) and motifs in Claspin mediate the regulated binding of Chk1. Nat. Cell
35S-labeled Claspin fragments were incubated for 100 min in egg Biol. 5, 161–165.
extracts (50 l) containing 100 g/ml cycloheximide in the absence
Kumagai, A., Guo, Z., Emami, K.H., Wang, S.X., and Dunphy, W.G.or presence of 50g/ml pA-pT. The beads were isolated by centrifu-
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